Global Neurovascular Devices Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4342111
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
The Global Neurovascular Device Market is Expected to Grow at a CAGR of 9% During 2016-2023

FEATURED COMPANIES

  • Depuy Synthes (U.S.)
  • Integer  (U.S.)
  • Johnson & Johnson  (U.S.)
  • Medtronic Plc  (U.S.)
  • Penumbra, Inc. (U.S.)
  • Phenox (Germany)
  • MORE

Neurovascular devices are those devices which are used for the treatment of neurovascular diseases such as as brain aneurysms, carotid artery disease, arteriovenous malformations and intracranial atherosclerotic disease. Some of the neaurovascular devices are such as stents , guide wires, catheters, embolic coils etc. The global neurovascular device market is expected to grow at a CAGR of 9% during the forecast period 2016-2023. These neurovasular devices offers several advantages such as  flexible to use due to its capability of shape transformation, controlled porosity  and is made up of low profile fabrics with thickness of 40-50 µm. Neurovascular  devices are being extensively used by the  neurosurgeons for the treatment of neurovasculoar diseases in hospitals, clinics and ambulatory surgical units.

North America is the largest market region for global neurovascular devices market and had accounted for the highest market revenue share in 2016. The key factor driving the market growth in North America is the increased adoption of neurovascular devices by the neurosurgeons for the treatment of neurovascular disease, growing number of clinical trials and notable medical remuneration available in the United States for neurosurgical treatment procedures. Moreover, in 2015, North America accounted for 72% market revenue share. Another factor favoring the market growth in North America is the rising healthcare expenditure, favorable medical remuneration policies, technological advancements in neurosurgeries and development of healthcare infrastructure. However, Asia Pacific is anticipated to emerge as the fastest growing market region with the highest CAGR of 6% through 2023. This is due to the increasing prevalence of brain aneurysm in the Asia Pacific region.

The global neurovascular devices market is influenced by the presence of leading biotechnology companies such as Stryker Corporation, Medtronic PLC, Johnson & Johnson, Terumo Corporation, Penumbra Inc. etc. Product launches, joint venture, merger and acquisition are some of the crucial strategies adopted by the key market players to gain competitive advantage.

Global neurovascular devices market report covers segmentation analysis of product type, disease pathology and end users. Report further covers segments of product type which includes aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurovascular support devices and neuro thrombectomy devices. The aneurysm coiling and embolization devices segment is anticipated to account for the largest market revenue in 2016. The key factor driving this segment growth is the increased adoption of embolic coils for the neurovascular treatment. Report further covers segments of disease pathologies which include ischemic strokes, cerebral aneurysms, arteriovenous malformation and fistulas etc. The ischemic stroke is the leading segment and had accounted for largest market revenue share in 2016. Increasing risk of ischemic stroke among the large population of people worldwide due to diabetes and smoking is contributing significantly to the market growth, whereas the end users of neurovascular devices include hospitals, clinics and ambulatory surgical units.



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Depuy Synthes (U.S.)
  • Integer  (U.S.)
  • Johnson & Johnson  (U.S.)
  • Medtronic Plc  (U.S.)
  • Penumbra, Inc. (U.S.)
  • Phenox (Germany)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
 
2. Market Overview
2.1. Global Neurovascular Devices Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis And Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment
 
3. Market Determinants
3.1. Market Drivers
3.1.1. Rising Geriatric Population
3.1.2. Large Target Patient Population
3.1.3. Growing Market Demand for Effective Neurovascular Devices
3.1.4. Availability of a Variety of Neurovascular Devices
3.2. Market Restraints
3.2.1. Stringent Regulations
3.2.2. Need for Designing More Effective And Low- Cost Treatments
3.3. Market Opportunities
3.3.1. Increasing Research Activities in the Field of Neurovascular Therapies
3.3.2. Rising Demand for Minimally Invasive Neurosurgical Procedures
3.3.3. Technological Advancements
3.4.   Market Challenges
3.4.1.  Lack of Skilled Neurosurgeons
3.4.2. Companies Are Facing Challenges in Commercialization Across the Developing Economies
 
4. Market Segmentation
4.1. Global Neurovascular Devices   Market By Product  Type
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4.  Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global   Aneurysm Coiling & Embolization Devices Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.1.5.1.3. Top Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global   Cerebral Balloon Angioplasty And Stenting Systems Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.1.5.2.3. Top Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.3. Global  Neurovascular Support Devices Market
4.1.5.3.1. Adoption Scenario & Market Determinants
4.1.5.3.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.1.5.3.3. Top Players & Key Products
4.1.5.3.4. Key Conclusions
4.1.5.4. Global  Neurothrombectomy Devices Market
4.1.5.4.1. Adoption Scenario & Market Determinants
4.1.5.4.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.1.5.4.3. Top Players & Key Products
4.1.5.4.4. Key Conclusions
4.2. Global Neurovascular Devices   Market By Se Disease Pathology
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4.  Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Ischemic Strokes Market
4.2.5.1.1. Adoption Scenario & Market Determinants
4.2.5.1.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.2.5.1.3. Top Players & Key Products
4.2.5.1.4. Key Conclusions
4.2.5.2. Global Cerebral Aneurysms Market
4.2.5.2.1. Adoption Scenario & Market Determinants
4.2.5.2.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.2.5.2.3. Top Players & Key Products
4.2.5.2.4. Key Conclusions
4.2.5.3. Global  Arteriovenous Malformation And Fistulas  Market
4.2.5.3.1. Adoption Scenario & Market Determinants
4.2.5.3.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.2.5.3.3. Top Players & Key Products
4.2.5.3.4. Key Conclusions
4.2.5.4. Global  Other Disease Pathologiesmarket
4.2.5.4.1. Adoption Scenario & Market Determinants
4.2.5.4.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.2.5.4.3. Top Players & Key Products
4.2.5.4.4. Key Conclusions
4.3. Global Neurovascular Devices  Market By End Users
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4.  Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Hospitals  Market
4.3.5.1.1. Adoption Scenario & Market Determinants
4.3.5.1.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.3.5.1.3. Top Players & Key Products
4.3.5.1.4. Key Conclusions
4.3.5.2. Global Clinics   Market
4.3.5.2.1. Adoption Scenario & Market Determinants
4.3.5.2.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.3.5.2.3. Top Players & Key Products
4.3.5.2.4. Key Conclusions
4.3.5.3. Global Ambulatory Surgical Units  Market
4.3.5.3.1. Adoption Scenario & Market Determinants
4.3.5.3.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.3.5.3.3. Top Players & Key Products
4.3.5.3.4. Key Conclusions
4.3.5.4. Global Other Applications  Market
4.3.5.4.1. Adoption Scenario & Market Determinants
4.3.5.4.2. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
4.3.5.4.3. Top Players & Key Products
4.3.5.4.4. Key Conclusions
 
5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers And Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships
 
6. Geographical Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4.  Global Neurovascular Devices  Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.1.2.1.2. Top Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.1.2.2.2. Top Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.2.2.1.2. Top Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.2.2.2.2. Top Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.2.2.3.2. Top Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.2.2.4.2. Top Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.2.2.5.2. Top Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.3.2.1.2. Top Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts   2014-2023 ($ Million)
6.4.3.2.2.2. Top Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.3.2.3.2. Top Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.3.2.4.2. Top Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.3.2.5.2. Top Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.4.2.1.2. Top Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecastsforecast 2014-2023 ($ Million)
6.4.4.2.2.2. Top Players & Key Products
6.4.4.2.2.3. Key Conclusions
 
7. Company Profiles
7.1.   Medtronic Plc  (U.S.)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Key Innovation Sector
7.1.4. Strategic Initiatives
7.1.5. Scot Analysis
7.1.6. Strategic Analysis
7.2. Stryker  Corporation (U.S.)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Key Innovation Sector
7.2.4. Strategic Initiatives
7.2.5. Scot Analysis
7.2.6. Strategic Analysis
7.3. Johnson & Johnson  (U.S.)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Key Innovation Sector
7.3.4. Strategic Initiatives
7.3.5. Scot Analysis
7.3.6. Strategic Analysis
7.4. Terumo Corporation (Japan)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Key Innovation Sector
7.4.4. Strategic Initiatives
7.4.5. Scot Analysis
7.4.6. Strategic Analysis
7.5. Penumbra, Inc. (U.S.)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Key Innovation Sector
7.5.4. Strategic Initiatives
7.5.5. Scot Analysis
7.5.6. Strategic Analysis
7.6. Boston Scientific Corporation.  (U.S.)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Key Innovation Sector
7.6.4. Strategic Initiatives
7.6.5. Scot Analysis
7.6.6. Strategic Analysis
7.7. Microport Scientific Corporation. (China)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Key Innovation Sector
7.7.4. Strategic Initiatives
7.7.5. Scot Analysis
7.7.6. Strategic Analysis
7.8. Merit Medical Systems, Inc. (U.S.)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Key Innovation Sector
7.8.4. Strategic Initiatives
7.8.5. Scot Analysis
7.8.6. Strategic Analysis
7.9. W.L. Gore & Associates, Inc. (U.S.)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Key Innovation Sector
7.9.4. Strategic Initiatives
7.9.5. Scot Analysis
7.9.6. Strategic Analysis
7.10. Abbott Laboratories (U.S.)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Key Innovation Sector
7.10.4. Strategic Initiatives
7.10.5. Scot Analysis
7.10.6. Strategic Analysis
7.11.  Integer  (U.S.)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Key Innovation Sector
7.11.4. Strategic Initiatives
7.11.5. Scot Analysis
7.11.6. Strategic Analysis
7.12. Blockade Medical Llc  (U.S.)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Key Innovation Sector
7.12.4. Strategic Initiatives
7.12.5. Scot Analysis
7.12.6. Strategic Analysis
7.13. Depuy Synthes (U.S.)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Key Innovation Sector
7.13.4. Strategic Initiatives
7.13.5. Scot Analysis
7.13.6. Strategic Analysis
7.14. Phenox (Germany)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Key Innovation Sector
7.14.4. Strategic Initiatives
7.14.5. Scot Analysis
7.14.6. Strategic Analysis
7.15. Secant Medical  (U.S.)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Key Innovation Sector
7.15.4. Strategic Initiatives
7.15.5. Scot Analysis
7.15.6. Strategic Analysis
 
List of Tables
1. Global Neurovascular Devices Market By Product Type 2014-2023 ($ Million)
2. Global Aneurysm Coiling & Embolization Devices Market By Geography 2014-2023 ($ Million)
3. Global Cerebral Balloon Angioplasty And Stenting Systems Market By Geography 2014-2023 ($ Million)
4. Global Neurovascular  Support Devices Market By Geography 2014-2023 ($ Million)
5. Global Neurothrombectomy Devices Market By Geography 2014-2023 ($ Million)
6. Global Neurovascular Devices   Market By Disease Pathology2014-2023 ($ Million)
7. Global Ischemic Strokes Market By Geography 2014-2023 ($ Million)
8. Global Cerebral Aneurysms Market  By Geography 2014-2023 ($ Million)
9. Global Arteriovenous Malformation And Fistulas  Market By Geography 2014-2023 ($ Million)
10. Global Other Disease Pathologies Market  By Geography 2014-2023 ($ Million)
11. Global  Neurovascular Devices   Market By  End Users 2014-2023 ($ Million)
12. Global  Hospital   Market By Geography 2014-2023 ($ Million)
13. Global  Clinic  Market  By Geography 2014-2023 ($ Million)
14. Global  Ambulatory Surgical Units   Market  By Geography 2014-2023 ($ Million)
15. Global  Other Applications  Market  By Geography 2014-2023 ($ Million)
16. North America Neurovascular Devices  Market 2014-2023 ($ Million)
17. Europe Neurovascular Devices  Market 2014-2023 ($ Million)
18. Asia Pacific Neurovascular Devices Market 2014-2023 ($ Million)
19. Rest of the World Neurovascular Devices Market 2014-2023 ($ Million)
 
List of Figures
1. Global Neurovascular Devices Market 2014-2023 ($ Million)
2. Global Aneurysm Coiling & Embolization Devices Market 2014-2023 ($ Million)
3. Global Cerebral Balloon Angioplasty And Stenting Systems Market 2014-2023 ($ Million)
4. Global Neurovascular  Support Devices Market 2014-2023 ($ Million)
5. Global Neurothrombectomy Devices Market 2014-2023 ($ Million)
6. Global Ischemic Strokes Market 2014-2023 ($ Million)
7. Global Cerebral Aneurysms Market  2014-2023 ($ Million)
8. Global Arteriovenous Malformation And Fistulas   Market 2014-2023 ($ Million)
9. Global Other Disease Pathologies Market  2014-2023 ($ Million)
10. Global  Hospital   Market  2014-2023 ($ Million)
11. Global  Clinic  Market   2014-2023 ($ Million)
12. Global  Ambulatory Surgical Units  Market   2014-2023 ($ Million)
13. Global  Other Applications  Market   2014-2023 ($ Million)
14. United States (U.S.) Neurovascular Devices  Market 2014-2023 ($ Million)
15. Canada Neurovascular Devices  Market 2014-2023 ($ Million)
16. United Kingdom (Uk) Neurovascular Devices Market 2014-2023 ($ Million)
17. France Neurovascular Devices  Market 2014-2023 ($ Million)
18. Germany Neurovascular Devices Market 2014-2023 ($ Million)
19. Spain Neurovascular Devices Market 2014-2023 ($ Million)
20. Roe Neurovascular Devices Market 2014-2023 ($ Million)
21. India Neurovascular Devices Market 2014-2023 ($ Million)
22. China Neurovascular Devices Market 2014-2023 ($ Million)
23. Japan Neurovascular Devices Market 2014-2023 ($ Million)
24. Australia Neurovascular Devices Market 2014-2023 ($ Million)
25. Roapac Neurovascular Devices Market 2014-2023 ($ Million)
26. Latin America Neurovascular Devices Market 2014-2023 ($ Million)
27. Mena Neurovascular Devices Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories (U.S.)
  • Blockade Medical Llc  (U.S.)
  • Boston Scientific Corporation.  (U.S.)
  • Depuy Synthes (U.S.)
  • Integer  (U.S.)
  • Johnson & Johnson  (U.S.)
  • Medtronic Plc  (U.S.)
  • Merit Medical Systems, Inc. (U.S.)
  • Microport Scientific Corporation. (China)
  • Penumbra, Inc. (U.S.)
  • Phenox (Germany)
  • Secant Medical  (U.S.)
  • Stryker  Corporation (U.S.)
  • Terumo Corporation (Japan)
  • W.L. Gore & Associates, Inc. (U.S.)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll